<DOC>
	<DOCNO>NCT00544921</DOCNO>
	<brief_summary>To test safety GLY-230 evaluate long drug stay blood take mouth .</brief_summary>
	<brief_title>Phase 1 Study Anti-glycation Agent GLY-230 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Men age 1855 Negative drug screen Normal EKG , clinical chemistry , CBC , urinalysis , Give write informed consent Active concomitant serious medical surgical disease , Hepatic renal laboratory value reference range , ise experimental drug within previous 30 day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>